title: Serum sickness-like reaction due to Infliximab reintroduction during pregnancy.
authors.forename: Anne
authors.initials: A
authors.lastname: Grosen
authors.forename: Mette
authors.initials: M
authors.lastname: Julsgaard
authors.forename: Lisbet Ambrosius
authors.initials: LA
authors.lastname: Christensen
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*; D012713:Serum Sickness / Q000139:chemically induced*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D000069285:Infliximab